|
|
||||||||
American Journal of Roentgenology, Vol 169, 977-983, Copyright © 1997 by American Roentgen Ray Society
ARTICLES |
EA Kazerooni, FJ Martinez, A Flint, DA Jamadar, BH Gross, DL Spizarny, PN Cascade, RI Whyte, JP Lynch 3rd and G Toews
Department of Radiology, University of Michigan Hospitals, Ann Arbor 48109-0326, USA.
OBJECTIVE: The purpose of our study was to determine if three-level thin-section CT depicts idiopathic pulmonary fibrosis (IPF) pathology as accurately as CT obtained at 10-mm increments throughout the entire lungs. SUBJECTS AND METHODS: Thin-section (1.0- to 1.5-mm) images at 10- mm increments were obtained and scored prospectively in 25 consecutive patients with newly diagnosed IPF who were participating in a Special Center of Research grant for interstitial lung disease. Each patient's lobe was scored by four thoracic radiologists on a scale of 0-5 for both ground-glass attenuation and fibrosis. The radiologists used three images (limited CT) and also used the entire data set (complete CT). CT scores were compared with pathology scores from 67 open and thoracoscopic biopsies. Limited and complete scores were compared with each other (Pearson correlation coefficient). Interobserver variation in the CT scoring system was assessed using kappa values. RESULTS: CT fibrosis scores strongly correlated with pathology fibrosis scores for complete (r = .53, p = .0001) and limited (r = .50, p = .0001) CT. CT ground-glass scores correlated with the histologic inflammatory scores for each lobe on complete (r = .27, p = .03) and limited (r = .26, p = .03) CT. The desquamative subcomponent of the pathology inflammatory score had the highest correlation with the CT ground-glass scores (complete: r = .29, p = .01; limited: r = .33, p = .007). Good interobserver agreement existed for both the alveolar and fibrosis components of the CT scoring system (kappa values ranging from .51 to .83) for each lobe of the lung on limited and complete CT. CONCLUSION: Limited thin-section CT reveals the pathologic changes associated with IPF as well as CT obtained at 10-mm increments. An added advantage of limited thin-section CT is that it exposes patients to less radiation.
This article has been cited by other articles:
![]() |
M. Thomeer, M. Demedts, J. Behr, R. Buhl, U. Costabel, C. D. R. Flower, J. Verschakelen, F. Laurent, A. G. Nicholson, E. K. Verbeken, et al. Multidisciplinary interobserver agreement in the diagnosis of idiopathic pulmonary fibrosis Eur. Respir. J., March 1, 2008; 31(3): 585 - 591. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Sumikawa, T. Johkoh, T. V. Colby, K. Ichikado, M. Suga, H. Taniguchi, Y. Kondoh, T. Ogura, H. Arakawa, K. Fujimoto, et al. Computed Tomography Findings in Pathological Usual Interstitial Pneumonia: Relationship to Survival Am. J. Respir. Crit. Care Med., February 15, 2008; 177(4): 433 - 439. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Zisman, A. S. Karlamangla, D. J. Ross, M. P. Keane, J. A. Belperio, R. Saggar, J. P. Lynch III, A. Ardehali, and J. Goldin High-Resolution Chest CT Findings Do Not Predict the Presence of Pulmonary Hypertension in Advanced Idiopathic Pulmonary Fibrosis Chest, September 1, 2007; 132(3): 773 - 779. [Abstract] [Full Text] [PDF] |
||||
![]() |
D Frezza, V Giambra, B Tolusso, M De Santis, S Bosello, S Vettori, G Triolo, G Valentini, and G Ferraccioli Polymorphism of immunoglobulin enhancer element HS1,2A: allele *2 associates with systemic sclerosis. Comparison with HLA-DR and DQ allele frequency Ann Rheum Dis, September 1, 2007; 66(9): 1210 - 1215. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. P. Tiev, J. Cabane, F. Aubourg, A. Kettaneh, M. Ziani, L. Mouthon, S. Duong-Quy, I. Fajac, L. Guillevin, and A. T. Dinh-Xuan Severity of scleroderma lung disease is related to alveolar concentration of nitric oxide Eur. Respir. J., July 1, 2007; 30(1): 26 - 30. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Roger Parra, R. Adib Kairalla, C. R. R. de Carvalho, and V. L. Capelozzi Abnormal deposition of collagen/elastic vascular fibres and prognostic significance in idiopathic interstitial pneumonias Thorax, May 1, 2007; 62(5): 428 - 437. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Nakanishi, Y. Demura, S. Mizuno, S. Ameshima, Y. Chiba, I. Miyamori, H. Itoh, M. Kitaichi, and T. Ishizaki Changes in HRCT findings in patients with respiratory bronchiolitis-associated interstitial lung disease after smoking cessation Eur. Respir. J., March 1, 2007; 29(3): 453 - 461. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Chonan, O. Taguchi, and K. Omae Interstitial pulmonary disorders in indium-processing workers Eur. Respir. J., February 1, 2007; 29(2): 317 - 324. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. R. Parra, W. R. Teodoro, A. P. P. Velosa, C. C. de Oliveira, N. H. Yoshinari, and V. L. Capelozzi Interstitial and Vascular Type V Collagen Morphologic Disorganization in Usual Interstitial Pneumonia J. Histochem. Cytochem., December 1, 2006; 54(12): 1315 - 1325. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Lebtahi, S. Moreau, S. Marchand-Adam, M.-P. Debray, M. Brauner, P. Soler, J. Marchal, O. Raguin, A. Gruaz-Guyon, J.-C. Reubi, et al. Increased Uptake of 111In-Octreotide in Idiopathic Pulmonary Fibrosis J. Nucl. Med., August 1, 2006; 47(8): 1281 - 1287. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Pignatti, G. Brunetti, D. Moretto, M.-R. Yacoub, M. Fiori, B. Balbi, A. Balestrino, G. Cervio, S. Nava, and G. Moscato Role of the Chemokine Receptors CXCR3 and CCR4 in Human Pulmonary Fibrosis Am. J. Respir. Crit. Care Med., February 1, 2006; 173(3): 310 - 317. [Abstract] [Full Text] [PDF] |
||||
![]() |
E S Choi, E M Pierce, C Jakubzick, K J Carpenter, S L Kunkel, H Evanoff, F J Martinez, K R Flaherty, B B Moore, G B Toews, et al. Focal interstitial CC chemokine receptor 7 (CCR7) expression in idiopathic interstitial pneumonia J. Clin. Pathol., January 1, 2006; 59(1): 28 - 39. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Demedts, J. Behr, R. Buhl, U. Costabel, R. Dekhuijzen, H. M. Jansen, W. MacNee, M. Thomeer, B. Wallaert, F. Laurent, et al. High-Dose Acetylcysteine in Idiopathic Pulmonary Fibrosis. N. Engl. J. Med., November 24, 2005; 353(21): 2229 - 2242. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-C. Chang, C.-J. Yu, S.-C. Chang, J. R. Galvin, H.-M. Liu, C.-H. Hsiao, P.-H. Kuo, K.-Y. Chen, T. J. Franks, K.-M. Huang, et al. Pulmonary Sequelae in Convalescent Patients after Severe Acute Respiratory Syndrome: Evaluation with Thin-Section CT Radiology, September 1, 2005; 236(3): 1067 - 1075. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. de Jong, N. L. Muller, P. D. Pare, and H. O. Coxson Computed tomographic imaging of the airways: relationship to structure and function Eur. Respir. J., July 1, 2005; 26(1): 140 - 152. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Jegal, D. S. Kim, T. S. Shim, C.-M. Lim, S. Do Lee, Y. Koh, W. S. Kim, W. D. Kim, J. S. Lee, W. D. Travis, et al. Physiology Is a Stronger Predictor of Survival than Pathology in Fibrotic Interstitial Pneumonia Am. J. Respir. Crit. Care Med., March 15, 2005; 171(6): 639 - 644. [Abstract] [Full Text] [PDF] |
||||
![]() |
Task Force members, N. Galie, A. Torbicki, R. Barst, P. Dartevelle, S. Haworth, T. Higenbottam, H. Olschewski, A. Peacock, G. Pietra, et al. Guidelines on diagnosis and treatment of pulmonary arterial hypertension: The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology Eur. Heart J., December 2, 2004; 25(24): 2243 - 2278. [Full Text] [PDF] |
||||
![]() |
K. R. Flaherty, T. E. King Jr., G. Raghu, J. P. Lynch III, T. V. Colby, W. D. Travis, B. H. Gross, E. A. Kazerooni, G. B. Toews, Q. Long, et al. Idiopathic Interstitial Pneumonia: What Is the Effect of a Multidisciplinary Approach to Diagnosis? Am. J. Respir. Crit. Care Med., October 15, 2004; 170(8): 904 - 910. [Abstract] [Full Text] [PDF] |
||||
![]() |
N R Simler, P E Brenchley, A W Horrocks, S M Greaves, P S Hasleton, and J J Egan Angiogenic cytokines in patients with idiopathic interstitial pneumonia Thorax, July 1, 2004; 59(7): 581 - 585. [Abstract] [Full Text] [PDF] |
||||
![]() |
C Jakubzick, E S Choi, S L Kunkel, H Evanoff, F J Martinez, R K Puri, K R Flaherty, G B Toews, T V Colby, E A Kazerooni, et al. Augmented pulmonary IL-4 and IL-13 receptor subunit expression in idiopathic interstitial pneumonia J. Clin. Pathol., May 1, 2004; 57(5): 477 - 486. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. N. Lama, K. R. Flaherty, G. B. Toews, T. V. Colby, W. D. Travis, Q. Long, S. Murray, E. A. Kazerooni, B. H. Gross, J. P. Lynch III, et al. Prognostic Value of Desaturation during a 6-Minute Walk Test in Idiopathic Interstitial Pneumonia Am. J. Respir. Crit. Care Med., November 1, 2003; 168(9): 1084 - 1090. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Kaminski, J. A. Belperio, P. B. Bitterman, L. Chen, S. W. Chensue, A. M.K. Choi, S. Dacic, J. H. Dauber, R. M. du Bois, J. J. Enghild, et al. Idiopathic Pulmonary Fibrosis Am. J. Respir. Cell Mol. Biol., September 1, 2003; 29(3): S1 - 105. [Full Text] [PDF] |
||||
![]() |
K. R. Flaherty, J. A. Mumford, S. Murray, E. A. Kazerooni, B. H. Gross, T. V. Colby, W. D. Travis, A. Flint, G. B. Toews, J. P. Lynch III, et al. Prognostic Implications of Physiologic and Radiographic Changes in Idiopathic Interstitial Pneumonia Am. J. Respir. Crit. Care Med., September 1, 2003; 168(5): 543 - 548. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Wittram, E. J. Mark, and T. C. McLoud CT-Histologic Correlation of the ATS/ERS 2002 Classification of Idiopathic Interstitial Pneumonias RadioGraphics, September 1, 2003; 23(5): 1057 - 1071. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. R. Flaherty, T. V. Colby, W. D. Travis, G. B. Toews, J. Mumford, S. Murray, V. J. Thannickal, E. A. Kazerooni, B. H. Gross, J. P. Lynch III, et al. Fibroblastic Foci in Usual Interstitial Pneumonia: Idiopathic versus Collagen Vascular Disease Am. J. Respir. Crit. Care Med., May 15, 2003; 167(10): 1410 - 1415. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kuwano, N. Nakashima, I. Inoshima, N. Hagimoto, M. Fujita, M. Yoshimi, T. Maeyama, N. Hamada, K. Watanabe, and N. Hara Oxidative stress in lung epithelial cells from patients with idiopathic interstitial pneumonias Eur. Respir. J., February 1, 2003; 21(2): 232 - 240. [Abstract] [Full Text] [PDF] |
||||
![]() |
K R Flaherty, E L Thwaite, E A Kazerooni, B H Gross, G B Toews, T V Colby, W D Travis, J A Mumford, S Murray, A Flint, et al. Radiological versus histological diagnosis in UIP and NSIP: survival implications Thorax, February 1, 2003; 58(2): 143 - 148. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.R. Flaherty, G.B. Toews, W.D. Travis, T.V. Colby, E.A. Kazerooni, B.H. Gross, A. Jain, R.L. Strawderman III, R. Paine, A. Flint, et al. Clinical significance of histological classification of idiopathic interstitial pneumonia Eur. Respir. J., February 1, 2002; 19(2): 275 - 283. [Abstract] [Full Text] [PDF] |
||||
![]() |
American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias . This Joint Statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS Board of Directors, June 2001 and by The ERS Executive Committee, June 2001 Am. J. Respir. Crit. Care Med., January 15, 2002; 165(2): 277 - 304. [Full Text] [PDF] |
||||
![]() |
N Mogulkoc, M H Brutsche, P W Bishop, B Murby, M S Greaves, A W Horrocks, M Wilson, C McCullough, M Prescott, and J J Egan Pulmonary 99mTc-DTPA aerosol clearance and survival in usual interstitial pneumonia (UIP) Thorax, December 1, 2001; 56(12): 916 - 923. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Kazerooni High-Resolution CT of the Lungs Am. J. Roentgenol., September 1, 2001; 177(3): 501 - 519. [Full Text] [PDF] |
||||
![]() |
T. J. Gross and G. W. Hunninghake Idiopathic Pulmonary Fibrosis N. Engl. J. Med., August 16, 2001; 345(7): 517 - 525. [Full Text] [PDF] |
||||
![]() |
G. W. HUNNINGHAKE, M. B. ZIMMERMAN, D. A. SCHWARTZ, T. E. KING JR., J. LYNCH, R. HEGELE, J. WALDRON, T. COLBY, N. MULLER, D. LYNCH, et al. Utility of a Lung Biopsy for the Diagnosis of Idiopathic Pulmonary Fibrosis Am. J. Respir. Crit. Care Med., July 15, 2001; 164(2): 193 - 196. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. MOGULKOC, M. H. BRUTSCHE, P. W. BISHOP, S. M. GREAVES, A. W. HORROCKS, and J. J. EGAN Pulmonary Function in Idiopathic Pulmonary Fibrosis and Referral for Lung Transplantation Am. J. Respir. Crit. Care Med., July 1, 2001; 164(1): 103 - 108. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Michaelson, S. M. Aguayo, and J. Roman Idiopathic Pulmonary Fibrosis : A Practical Approach for Diagnosis and Management Chest, September 1, 2000; 118(3): 788 - 794. [Full Text] [PDF] |
||||
![]() |
H. TAKAHASHI, T. FUJISHIMA, H. KOBA, S. MURAKAMI, K. KUROKAWA, Y. SHIBUYA, M. SHIRATORI, Y. KUROKI, and S. ABE Serum Surfactant Proteins A and D as Prognostic Factors in Idiopathic Pulmonary Fibrosis and Their Relationship to Disease Extent Am. J. Respir. Crit. Care Med., September 1, 2000; 162(3): 1109 - 1114. [Abstract] [Full Text] |
||||
![]() |
D. A. Zisman, J. P. Lynch III, G. B. Toews, E. A. Kazerooni, A. Flint, and F. J. Martinez Cyclophosphamide in the Treatment of Idiopathic Pulmonary Fibrosis : A Prospective Study in Patients Who Failed To Respond to Corticosteroids Chest, June 1, 2000; 117(6): 1619 - 1626. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. GAY, E. A. KAZEROONI, G. B. TOEWS, J. P. LYNCH III, B. H. GROSS, P. N. CASCADE, D. L. SPIZARNY, A. FLINT, M. ANTHONY SCHORK, R. I. WHYTE, et al. Idiopathic Pulmonary Fibrosis . Predicting Response to Therapy and Survival Am. J. Respir. Crit. Care Med., April 1, 1998; 157(4): 1063 - 1072. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |